文献速递临床试验与 GCP流行病学与生物统计

方案论文:多中心随机对照试验评估临床前糖尿病评估与映射护理规划干预在1型、2型或糖尿病前期成人中的应用

Protocol paper: multi-Centre randomised controlled trial evaluating a pre-clinic diabetes assessment and mapped care planning intervention amongst adults with type 1, type 2 or pre-diabetes.
PubMed 文献 · Trials · 2022-06-20

该多中心平行组个体随机试验在最多10个中心纳入200例1型、2型或糖尿病前期成人,比较Spotlight Consultations临床前评估与常规护理对门诊咨询时长的影响。主要结局为常规门诊咨询时长,次要结局包括功能性健康状态、糖尿病痛苦、抑郁、治疗满意度、自我照护行为、医务人员职业倦怠、低血糖(低于70mg/dL时间)、高血糖(高于180mg/dL时间)、体重变化、HbA1c变化及干预成本效果。

要点

  • 试验比较Spotlight Consultations临床前评估与常规护理,主要结局为门诊咨询时长。
  • 计划在最多10个中心纳入200例1型、2型或糖尿病前期成人。
  • 干预在预定常规门诊预约前1周内以门诊形式提供。

核心结论

  • 研究结果将为常规护理中患者与专业人员沟通实践提供见解,并视必要提出改进建议。
  • 若干预显示临床和成本有效,将利用参与者和医务人员的反馈在部署前进行改进,以支持改善沟通及相关健康结局。

研究设计与样本

  • 多中心、平行组、个体随机对照试验,比较使用Spotlight Consultations临床前评估的咨询时长与常规护理。
  • 计划在最多10个参与中心邀请200例参加常规护理门诊预约的1型、2型或糖尿病前期成人参与。
  • 干预为在预定常规门诊预约前1周内提供的门诊临床前干预。

关键数值与推荐

  • 主要结局测量:常规门诊咨询时长。
  • 次要结局测量:功能性健康状态、糖尿病痛苦、抑郁、治疗满意度、自我照护行为影响、医务人员职业倦怠、医务人员治疗满意度与负担、低血糖(低于70mg/dL时间)、高血糖(高于180mg/dL时间)、体重变化、HbA1c变化、干预成本效果。
  • 试验获威尔士REC7研究伦理委员会批准(21/WA/0020),注册号ISRCTN15511689,注册日期2021年11月10日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing therapeutic interventions to treat diabetes are well known, yet the majority of people with diabetes do not consistently achieve blood glucose targets (even individual therapy targets) for optimal health, despite the large range of treatment options available. Such outcomes have remained stubbornly poor for decades with <25% adults with diabetes achieving glycaemic targets. Patient behaviour, individually supported in routine clinical care, is an important missing component to improved outcomes, in a medical healthcare model not ideally suited to supporting successful diabetes management. METHODS: A multi-centre, parallel group, individually randomised trial comparing consultation duration in adults with type 1, type 2 or pre-diabetes using the Spotlight Consultations pre-clinic assessment compared to usual care in the Spotlight-AQ study. Two hundred adults with type 1, type 2 or pre-diabetes attending routine care outpatient appointments across up to ten participating sites will be invited to participate. INTERVENTION: An outpatient pre-clinic intervention delivered within 1 week prior to scheduled routine outpatient appointment. PRIMARY OUTCOME MEASURE: Duration of routine outpatient consultation. SECONDARY OUTCOME MEASURES: Functional health status Diabetes distress Depression Treatment satisfaction Impact on self-care behaviours HCP burnout HCP treatment satisfaction and burden Hypoglycaemia (time less than 70mg/dL) Hyperglycaemia (time above 180 mg/dL) Change in weight Change in HbA1c Cost effectiveness of intervention DISCUSSION: Results from the study will provide valuable insights into patient-professional communication practices within routine care and recommendations will be made, as necessary, for improvements to that. If the intervention is shown to be clinically and cost-effective, the feedback from participants and healthcare professionals will be used to make any improvements prior to its deployment to support improved communication and associated health outcomes. ETHICS AND DISSEMINATION: The trial was approved by the Wales REC7 Research Ethics Committee (21/WA/0020). Results will be disseminated through national and international conferences, scientific journals, newsletters, magazines and social media. Target audiences include consultants and other clinicians in diabetes, and medical professionals or scientists overall. TRIAL REGISTRATION: ISRCTN15511689 . Registered on 10 November 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kelly RC, Phiri P, Price H, et al. Protocol paper: multi-Centre randomised controlled trial evaluating a pre-clinic diabetes assessment and mapped care planning intervention amongst adults with type 1, type 2 or pre-diabetes. Trials. 2022. PMID: 35725626. doi:10.1186/s13063-022-06475-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。